Clinical Trial Update: Real-world Secukinumab Outcomes in Canadian HS Patients

View source ↗

Summary

A real-world study evaluating secukinumab for hidradenitis suppurativa in Canadian patients is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Secukinumab (secukinumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hidradenitis Suppurativa | Status: RECRUITING